Human tissue screening draft guidance should be converted into a rule -- Red Cross.
This article was originally published in The Gray Sheet
Executive Summary
PROCESSED HUMAN TISSUE FDA DRAFT GUIDANCE SHOULD UNDERGO FORMAL RULEMAKING, the American Red Cross says in July 20 comments on FDA's recent draft document on screening and donor testing of banked human tissue. "Adopting the requirements [of the guidance] as a rule will avoid confusion as to its applicability and reduce the potential for later legal challenge," ARC states.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.